Abstract
Polydatin ameliorates low-density lipoprotein cholesterol and lipid metabolism by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in triple-negative breast cancer with hyperlipidemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have